.png){kind=icon}
.png){kind=icon}
Return
Retrospective Study of Foramen Magnum Development in Patients with Achondroplasia Starting Vosoritide Before Age Three
.png){kind=icon}
PRE
AI
M
N
M
H
K
H
DOI：10.1016/j.gim.2026.102666.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Achondroplasia (ACH) is a monogenic skeletal dysplasia caused by gain-of-function variants in FGFR3, leading to impaired endochondral ossification and foramen magnum stenosis. Although vosoritide promotes endochondral ossification, its effects on foramen magnum development remain unclear. We evaluated the impact of early vosoritide administration on foramen magnum development in infants and young children with ACH using longitudinal magnetic resonance imaging (MRI).
Journal
IF:
6.2
Papers:
5.1K
Citations:
2.0W
Organization
Cited Papers